# Tatva Chintan Pharma Chem Ltd (TATVA)
> Exchange: NSE | Sector: Chemicals | ISIN: 

## Price
Current Price: ₹1187.5
Day Change: -0.02%
52W High: ₹1610
52W Low: ₹749.65
Market Cap: ₹2,930 Cr

## Valuation
P/E: 89.78
P/B: 3.88
EPS: ₹13.95
Book Value: ₹322.54
Dividend Yield: 0%

## Returns
1Y Return: -16.7%

## Profitability
ROE: 5.53%
ROCE: 1.94%
Debt/Equity: 0.15
Revenue Growth: 24%
Profit Growth: 907.5%
EBITDA Margin: 18.98%
Operating Margin: 13.47%

## About
Tatva Chintan Pharma Chem Ltd is a Specialty Chemicals company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Chemicals
Industry: Specialty Chemicals
Sub Industry: Unknown

## Business Model
Overview: Tatva Chintan Pharma Chem Ltd makes money through Manufactured commodity sales, Value-added products, Exports or institutional demand in Specialty Chemicals. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Chemicals.
Source: Derived from stock data
Revenue Streams:
- Manufactured commodity sales
- Value-added products
- Exports or institutional demand
Operating Model:
- Uses plants, mines, or processing assets to convert raw materials into industrial products.
- Realisation, utilisation, energy cost, logistics, and commodity cycles drive earnings.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 5 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:15.406Z
Price History Updated: 2026-05-18T22:58:47.820Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:47.820Z
Quant Updated: 2026-05-18T22:58:47.820Z
Sentiment Updated: 2026-05-18T22:58:47.820Z
Financials Status: current
Financials Updated: 2026-05-18T15:31:05.423Z
Financials Last Attempt: 2026-05-18T15:31:05.423Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2019)
Revenue: ₹136 Cr
Operating Profit: ₹23 Cr (OPM 17%)
Net Profit: ₹12 Cr
Tax: ₹19 Cr

## Annual P&L History
Mar 2019: Rev ₹136Cr | PAT ₹12Cr | OPM 17%
Mar 2020: Rev ₹206Cr | PAT ₹21Cr | OPM 17%
Mar 2021: Rev ₹263Cr | PAT ₹38Cr | OPM 21%

## Balance Sheet (Mar 2019)
Total Assets: ₹144 Cr
Total Liabilities: ₹144 Cr
Borrowings: ₹56 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Chintan Nitinkumar Shah, Chairman & MD
- Ishwar Ramanbhai Nayi, Company Secretary & Compliance Officer
- Ajaykumar Mansukhlal Patel, Whole Time Director
- Shekhar Rasiklal Somani, Whole Time Director
- Ajesh Kumar Mohanan Pillai, Chief Financial Officer

---
Source: rupiya.io/stocks/tatva
Disclaimer: For research and education only. Not investment advice.